Walk through the five-step model in this comprehensive evaluation of a biotech collaborative arrangement between BioTek and Farma to commercialize a drug compound.
Read More
Implementing ASC 606 requires a substantial amount of time and expertise, with specific challenges rising in each industry. Gain a deeper understanding of the key issues that life sciences entities face as they transition to ASC 606.
Review the basics of ASC 808, Collaborative Arrangements, and learn how ASC 606 applies when collaborators exchange consideration in an illustrative case study.
